0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Histone Deacetylase Inhibitors Market Research Report 2025
Published Date: January 2025
|
Report Code: QYRE-Auto-13W8731
Home | Market Reports | Science
Global Histone Deacetylase Inhibitors Market Insights Forecast to 2028
BUY CHAPTERS

Global Histone Deacetylase Inhibitors Market Research Report 2025

Code: QYRE-Auto-13W8731
Report
January 2025
Pages:68
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Histone Deacetylase Inhibitors Market Size

The global market for Histone Deacetylase Inhibitors was valued at US$ 1154 million in the year 2024 and is projected to reach a revised size of US$ 2540 million by 2031, growing at a CAGR of 12.1% during the forecast period.

Histone Deacetylase Inhibitors Market

Histone Deacetylase Inhibitors Market

Histone Deacetylase Inhibitors Product Introduction Histone deacetylase inhibitors (HDAC inhibitors, HDACi, HDIs) are chemical compounds that inhibit histone deacetylases.
HDIs have a long history of use in psychiatry and neurology as mood stabilizers and anti-epileptics. More recently they are being investigated as possible treatments for cancers, parasitic and inflammatory diseases…

Report Scope

This report aims to provide a comprehensive presentation of the global market for Histone Deacetylase Inhibitors, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Histone Deacetylase Inhibitors.
The Histone Deacetylase Inhibitors market size, estimations, and forecasts are provided in terms of sales volume (Doses) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Histone Deacetylase Inhibitors market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Histone Deacetylase Inhibitors manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Histone Deacetylase Inhibitors Market Report

Report Metric Details
Report Name Histone Deacetylase Inhibitors Market
Accounted market size in year US$ 1154 million
Forecasted market size in 2031 US$ 2540 million
CAGR 12.1%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
  • Belinostat
  • Romidepsin
  • Chidamide
Segment by Application
  • Cancer Treatment
  • Inflammatory Diseases
  • Other Diseases
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Merck, Celgene, Teva Pharms, Acrotech, Spectrum Pharmaceuticals
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Histone Deacetylase Inhibitors manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Histone Deacetylase Inhibitors in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

How fast is Histone Deacetylase Inhibitors Market growing?

Ans: The Histone Deacetylase Inhibitors Market witnessing a CAGR of 12.1% during the forecast period 2025-2031.

What is the Histone Deacetylase Inhibitors Market size in 2031?

Ans: The Histone Deacetylase Inhibitors Market size in 2031 will be US$ 2540 million.

Who are the main players in the Histone Deacetylase Inhibitors Market report?

Ans: The main players in the Histone Deacetylase Inhibitors Market are Merck, Celgene, Teva Pharms, Acrotech, Spectrum Pharmaceuticals

What are the Application segmentation covered in the Histone Deacetylase Inhibitors Market report?

Ans: The Applications covered in the Histone Deacetylase Inhibitors Market report are Cancer Treatment, Inflammatory Diseases, Other Diseases

What are the Type segmentation covered in the Histone Deacetylase Inhibitors Market report?

Ans: The Types covered in the Histone Deacetylase Inhibitors Market report are Belinostat, Romidepsin, Chidamide

1 Histone Deacetylase Inhibitors Market Overview
1.1 Product Definition
1.2 Histone Deacetylase Inhibitors by Type
1.2.1 Global Histone Deacetylase Inhibitors Market Value Comparison by Type (2024 VS 2031)
1.2.2 Belinostat
1.2.3 Romidepsin
1.2.4 Chidamide
1.3 Histone Deacetylase Inhibitors by Application
1.3.1 Global Histone Deacetylase Inhibitors Market Value by Application (2024 VS 2031)
1.3.2 Cancer Treatment
1.3.3 Inflammatory Diseases
1.3.4 Other Diseases
1.4 Global Histone Deacetylase Inhibitors Market Size Estimates and Forecasts
1.4.1 Global Histone Deacetylase Inhibitors Revenue 2020-2031
1.4.2 Global Histone Deacetylase Inhibitors Sales 2020-2031
1.4.3 Global Histone Deacetylase Inhibitors Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Histone Deacetylase Inhibitors Market Competition by Manufacturers
2.1 Global Histone Deacetylase Inhibitors Sales Market Share by Manufacturers (2020-2025)
2.2 Global Histone Deacetylase Inhibitors Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Histone Deacetylase Inhibitors Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Histone Deacetylase Inhibitors, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Histone Deacetylase Inhibitors, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Histone Deacetylase Inhibitors, Product Type & Application
2.7 Global Key Manufacturers of Histone Deacetylase Inhibitors, Date of Enter into This Industry
2.8 Global Histone Deacetylase Inhibitors Market Competitive Situation and Trends
2.8.1 Global Histone Deacetylase Inhibitors Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Histone Deacetylase Inhibitors Players Market Share by Revenue
2.8.3 Global Histone Deacetylase Inhibitors Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Histone Deacetylase Inhibitors Market Scenario by Region
3.1 Global Histone Deacetylase Inhibitors Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Histone Deacetylase Inhibitors Sales by Region: 2020-2031
3.2.1 Global Histone Deacetylase Inhibitors Sales by Region: 2020-2025
3.2.2 Global Histone Deacetylase Inhibitors Sales by Region: 2026-2031
3.3 Global Histone Deacetylase Inhibitors Revenue by Region: 2020-2031
3.3.1 Global Histone Deacetylase Inhibitors Revenue by Region: 2020-2025
3.3.2 Global Histone Deacetylase Inhibitors Revenue by Region: 2026-2031
3.4 North America Histone Deacetylase Inhibitors Market Facts & Figures by Country
3.4.1 North America Histone Deacetylase Inhibitors Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Histone Deacetylase Inhibitors Sales by Country (2020-2031)
3.4.3 North America Histone Deacetylase Inhibitors Revenue by Country (2020-2031)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Histone Deacetylase Inhibitors Market Facts & Figures by Country
3.5.1 Europe Histone Deacetylase Inhibitors Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Histone Deacetylase Inhibitors Sales by Country (2020-2031)
3.5.3 Europe Histone Deacetylase Inhibitors Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Histone Deacetylase Inhibitors Market Facts & Figures by Region
3.6.1 Asia Pacific Histone Deacetylase Inhibitors Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Histone Deacetylase Inhibitors Sales by Region (2020-2031)
3.6.3 Asia Pacific Histone Deacetylase Inhibitors Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Histone Deacetylase Inhibitors Market Facts & Figures by Country
3.7.1 Latin America Histone Deacetylase Inhibitors Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Histone Deacetylase Inhibitors Sales by Country (2020-2031)
3.7.3 Latin America Histone Deacetylase Inhibitors Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Histone Deacetylase Inhibitors Market Facts & Figures by Country
3.8.1 Middle East and Africa Histone Deacetylase Inhibitors Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Histone Deacetylase Inhibitors Sales by Country (2020-2031)
3.8.3 Middle East and Africa Histone Deacetylase Inhibitors Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Histone Deacetylase Inhibitors Sales by Type (2020-2031)
4.1.1 Global Histone Deacetylase Inhibitors Sales by Type (2020-2025)
4.1.2 Global Histone Deacetylase Inhibitors Sales by Type (2026-2031)
4.1.3 Global Histone Deacetylase Inhibitors Sales Market Share by Type (2020-2031)
4.2 Global Histone Deacetylase Inhibitors Revenue by Type (2020-2031)
4.2.1 Global Histone Deacetylase Inhibitors Revenue by Type (2020-2025)
4.2.2 Global Histone Deacetylase Inhibitors Revenue by Type (2026-2031)
4.2.3 Global Histone Deacetylase Inhibitors Revenue Market Share by Type (2020-2031)
4.3 Global Histone Deacetylase Inhibitors Price by Type (2020-2031)
5 Segment by Application
5.1 Global Histone Deacetylase Inhibitors Sales by Application (2020-2031)
5.1.1 Global Histone Deacetylase Inhibitors Sales by Application (2020-2025)
5.1.2 Global Histone Deacetylase Inhibitors Sales by Application (2026-2031)
5.1.3 Global Histone Deacetylase Inhibitors Sales Market Share by Application (2020-2031)
5.2 Global Histone Deacetylase Inhibitors Revenue by Application (2020-2031)
5.2.1 Global Histone Deacetylase Inhibitors Revenue by Application (2020-2025)
5.2.2 Global Histone Deacetylase Inhibitors Revenue by Application (2026-2031)
5.2.3 Global Histone Deacetylase Inhibitors Revenue Market Share by Application (2020-2031)
5.3 Global Histone Deacetylase Inhibitors Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Merck
6.1.1 Merck Company Information
6.1.2 Merck Description and Business Overview
6.1.3 Merck Histone Deacetylase Inhibitors Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Merck Histone Deacetylase Inhibitors Product Portfolio
6.1.5 Merck Recent Developments/Updates
6.2 Celgene
6.2.1 Celgene Company Information
6.2.2 Celgene Description and Business Overview
6.2.3 Celgene Histone Deacetylase Inhibitors Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Celgene Histone Deacetylase Inhibitors Product Portfolio
6.2.5 Celgene Recent Developments/Updates
6.3 Teva Pharms
6.3.1 Teva Pharms Company Information
6.3.2 Teva Pharms Description and Business Overview
6.3.3 Teva Pharms Histone Deacetylase Inhibitors Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Teva Pharms Histone Deacetylase Inhibitors Product Portfolio
6.3.5 Teva Pharms Recent Developments/Updates
6.4 Acrotech
6.4.1 Acrotech Company Information
6.4.2 Acrotech Description and Business Overview
6.4.3 Acrotech Histone Deacetylase Inhibitors Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Acrotech Histone Deacetylase Inhibitors Product Portfolio
6.4.5 Acrotech Recent Developments/Updates
6.5 Spectrum Pharmaceuticals
6.5.1 Spectrum Pharmaceuticals Company Information
6.5.2 Spectrum Pharmaceuticals Description and Business Overview
6.5.3 Spectrum Pharmaceuticals Histone Deacetylase Inhibitors Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Spectrum Pharmaceuticals Histone Deacetylase Inhibitors Product Portfolio
6.5.5 Spectrum Pharmaceuticals Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Histone Deacetylase Inhibitors Industry Chain Analysis
7.2 Histone Deacetylase Inhibitors Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Histone Deacetylase Inhibitors Production Mode & Process Analysis
7.4 Histone Deacetylase Inhibitors Sales and Marketing
7.4.1 Histone Deacetylase Inhibitors Sales Channels
7.4.2 Histone Deacetylase Inhibitors Distributors
7.5 Histone Deacetylase Inhibitors Customer Analysis
8 Histone Deacetylase Inhibitors Market Dynamics
8.1 Histone Deacetylase Inhibitors Industry Trends
8.2 Histone Deacetylase Inhibitors Market Drivers
8.3 Histone Deacetylase Inhibitors Market Challenges
8.4 Histone Deacetylase Inhibitors Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
 Table 1. Global Histone Deacetylase Inhibitors Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Histone Deacetylase Inhibitors Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Histone Deacetylase Inhibitors Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Histone Deacetylase Inhibitors Sales (Doses) of Key Manufacturers (2020-2025)
 Table 5. Global Histone Deacetylase Inhibitors Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Histone Deacetylase Inhibitors Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Histone Deacetylase Inhibitors Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Histone Deacetylase Inhibitors Average Price (US$/Dose) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Histone Deacetylase Inhibitors, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Histone Deacetylase Inhibitors, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Histone Deacetylase Inhibitors, Product Type & Application
 Table 12. Global Key Manufacturers of Histone Deacetylase Inhibitors, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Histone Deacetylase Inhibitors by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Histone Deacetylase Inhibitors as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Histone Deacetylase Inhibitors Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Histone Deacetylase Inhibitors Sales by Region (2020-2025) & (Doses)
 Table 18. Global Histone Deacetylase Inhibitors Sales Market Share by Region (2020-2025)
 Table 19. Global Histone Deacetylase Inhibitors Sales by Region (2026-2031) & (Doses)
 Table 20. Global Histone Deacetylase Inhibitors Sales Market Share by Region (2026-2031)
 Table 21. Global Histone Deacetylase Inhibitors Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Histone Deacetylase Inhibitors Revenue Market Share by Region (2020-2025)
 Table 23. Global Histone Deacetylase Inhibitors Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Histone Deacetylase Inhibitors Revenue Market Share by Region (2026-2031)
 Table 25. North America Histone Deacetylase Inhibitors Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Histone Deacetylase Inhibitors Sales by Country (2020-2025) & (Doses)
 Table 27. North America Histone Deacetylase Inhibitors Sales by Country (2026-2031) & (Doses)
 Table 28. North America Histone Deacetylase Inhibitors Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Histone Deacetylase Inhibitors Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Histone Deacetylase Inhibitors Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Histone Deacetylase Inhibitors Sales by Country (2020-2025) & (Doses)
 Table 32. Europe Histone Deacetylase Inhibitors Sales by Country (2026-2031) & (Doses)
 Table 33. Europe Histone Deacetylase Inhibitors Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Histone Deacetylase Inhibitors Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Histone Deacetylase Inhibitors Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Histone Deacetylase Inhibitors Sales by Region (2020-2025) & (Doses)
 Table 37. Asia Pacific Histone Deacetylase Inhibitors Sales by Region (2026-2031) & (Doses)
 Table 38. Asia Pacific Histone Deacetylase Inhibitors Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Histone Deacetylase Inhibitors Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Histone Deacetylase Inhibitors Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Histone Deacetylase Inhibitors Sales by Country (2020-2025) & (Doses)
 Table 42. Latin America Histone Deacetylase Inhibitors Sales by Country (2026-2031) & (Doses)
 Table 43. Latin America Histone Deacetylase Inhibitors Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Histone Deacetylase Inhibitors Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Histone Deacetylase Inhibitors Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Histone Deacetylase Inhibitors Sales by Country (2020-2025) & (Doses)
 Table 47. Middle East and Africa Histone Deacetylase Inhibitors Sales by Country (2026-2031) & (Doses)
 Table 48. Middle East and Africa Histone Deacetylase Inhibitors Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Histone Deacetylase Inhibitors Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Histone Deacetylase Inhibitors Sales (Doses) by Type (2020-2025)
 Table 51. Global Histone Deacetylase Inhibitors Sales (Doses) by Type (2026-2031)
 Table 52. Global Histone Deacetylase Inhibitors Sales Market Share by Type (2020-2025)
 Table 53. Global Histone Deacetylase Inhibitors Sales Market Share by Type (2026-2031)
 Table 54. Global Histone Deacetylase Inhibitors Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Histone Deacetylase Inhibitors Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Histone Deacetylase Inhibitors Revenue Market Share by Type (2020-2025)
 Table 57. Global Histone Deacetylase Inhibitors Revenue Market Share by Type (2026-2031)
 Table 58. Global Histone Deacetylase Inhibitors Price (US$/Dose) by Type (2020-2025)
 Table 59. Global Histone Deacetylase Inhibitors Price (US$/Dose) by Type (2026-2031)
 Table 60. Global Histone Deacetylase Inhibitors Sales (Doses) by Application (2020-2025)
 Table 61. Global Histone Deacetylase Inhibitors Sales (Doses) by Application (2026-2031)
 Table 62. Global Histone Deacetylase Inhibitors Sales Market Share by Application (2020-2025)
 Table 63. Global Histone Deacetylase Inhibitors Sales Market Share by Application (2026-2031)
 Table 64. Global Histone Deacetylase Inhibitors Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Histone Deacetylase Inhibitors Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Histone Deacetylase Inhibitors Revenue Market Share by Application (2020-2025)
 Table 67. Global Histone Deacetylase Inhibitors Revenue Market Share by Application (2026-2031)
 Table 68. Global Histone Deacetylase Inhibitors Price (US$/Dose) by Application (2020-2025)
 Table 69. Global Histone Deacetylase Inhibitors Price (US$/Dose) by Application (2026-2031)
 Table 70. Merck Company Information
 Table 71. Merck Description and Business Overview
 Table 72. Merck Histone Deacetylase Inhibitors Sales (Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
 Table 73. Merck Histone Deacetylase Inhibitors Product
 Table 74. Merck Recent Developments/Updates
 Table 75. Celgene Company Information
 Table 76. Celgene Description and Business Overview
 Table 77. Celgene Histone Deacetylase Inhibitors Sales (Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
 Table 78. Celgene Histone Deacetylase Inhibitors Product
 Table 79. Celgene Recent Developments/Updates
 Table 80. Teva Pharms Company Information
 Table 81. Teva Pharms Description and Business Overview
 Table 82. Teva Pharms Histone Deacetylase Inhibitors Sales (Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
 Table 83. Teva Pharms Histone Deacetylase Inhibitors Product
 Table 84. Teva Pharms Recent Developments/Updates
 Table 85. Acrotech Company Information
 Table 86. Acrotech Description and Business Overview
 Table 87. Acrotech Histone Deacetylase Inhibitors Sales (Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
 Table 88. Acrotech Histone Deacetylase Inhibitors Product
 Table 89. Acrotech Recent Developments/Updates
 Table 90. Spectrum Pharmaceuticals Company Information
 Table 91. Spectrum Pharmaceuticals Description and Business Overview
 Table 92. Spectrum Pharmaceuticals Histone Deacetylase Inhibitors Sales (Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
 Table 93. Spectrum Pharmaceuticals Histone Deacetylase Inhibitors Product
 Table 94. Spectrum Pharmaceuticals Recent Developments/Updates
 Table 95. Key Raw Materials Lists
 Table 96. Raw Materials Key Suppliers Lists
 Table 97. Histone Deacetylase Inhibitors Distributors List
 Table 98. Histone Deacetylase Inhibitors Customers List
 Table 99. Histone Deacetylase Inhibitors Market Trends
 Table 100. Histone Deacetylase Inhibitors Market Drivers
 Table 101. Histone Deacetylase Inhibitors Market Challenges
 Table 102. Histone Deacetylase Inhibitors Market Restraints
 Table 103. Research Programs/Design for This Report
 Table 104. Key Data Information from Secondary Sources
 Table 105. Key Data Information from Primary Sources
 Table 106. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Histone Deacetylase Inhibitors
 Figure 2. Global Histone Deacetylase Inhibitors Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Histone Deacetylase Inhibitors Market Share by Type: 2024 & 2031
 Figure 4. Belinostat Product Picture
 Figure 5. Romidepsin Product Picture
 Figure 6. Chidamide Product Picture
 Figure 7. Global Histone Deacetylase Inhibitors Market Value by Application (2020-2031) & (US$ Million)
 Figure 8. Global Histone Deacetylase Inhibitors Market Share by Application: 2024 & 2031
 Figure 9. Cancer Treatment
 Figure 10. Inflammatory Diseases
 Figure 11. Other Diseases
 Figure 12. Global Histone Deacetylase Inhibitors Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 13. Global Histone Deacetylase Inhibitors Market Size (2020-2031) & (US$ Million)
 Figure 14. Global Histone Deacetylase Inhibitors Sales (2020-2031) & (Doses)
 Figure 15. Global Histone Deacetylase Inhibitors Average Price (US$/Dose) & (2020-2031)
 Figure 16. Histone Deacetylase Inhibitors Report Years Considered
 Figure 17. Histone Deacetylase Inhibitors Sales Share by Manufacturers in 2024
 Figure 18. Global Histone Deacetylase Inhibitors Revenue Share by Manufacturers in 2024
 Figure 19. Global 5 and 10 Largest Histone Deacetylase Inhibitors Players: Market Share by Revenue in Histone Deacetylase Inhibitors in 2024
 Figure 20. Histone Deacetylase Inhibitors Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 21. Global Histone Deacetylase Inhibitors Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 22. North America Histone Deacetylase Inhibitors Sales Market Share by Country (2020-2031)
 Figure 23. North America Histone Deacetylase Inhibitors Revenue Market Share by Country (2020-2031)
 Figure 24. U.S. Histone Deacetylase Inhibitors Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 25. Canada Histone Deacetylase Inhibitors Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 26. Europe Histone Deacetylase Inhibitors Sales Market Share by Country (2020-2031)
 Figure 27. Europe Histone Deacetylase Inhibitors Revenue Market Share by Country (2020-2031)
 Figure 28. Germany Histone Deacetylase Inhibitors Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 29. France Histone Deacetylase Inhibitors Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. U.K. Histone Deacetylase Inhibitors Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. Italy Histone Deacetylase Inhibitors Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. Russia Histone Deacetylase Inhibitors Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 33. Asia Pacific Histone Deacetylase Inhibitors Sales Market Share by Region (2020-2031)
 Figure 34. Asia Pacific Histone Deacetylase Inhibitors Revenue Market Share by Region (2020-2031)
 Figure 35. China Histone Deacetylase Inhibitors Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. Japan Histone Deacetylase Inhibitors Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. South Korea Histone Deacetylase Inhibitors Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. India Histone Deacetylase Inhibitors Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. Australia Histone Deacetylase Inhibitors Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. Taiwan Histone Deacetylase Inhibitors Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Indonesia Histone Deacetylase Inhibitors Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. Thailand Histone Deacetylase Inhibitors Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. Malaysia Histone Deacetylase Inhibitors Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 44. Philippines Histone Deacetylase Inhibitors Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 45. Latin America Histone Deacetylase Inhibitors Sales Market Share by Country (2020-2031)
 Figure 46. Latin America Histone Deacetylase Inhibitors Revenue Market Share by Country (2020-2031)
 Figure 47. Mexico Histone Deacetylase Inhibitors Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 48. Brazil Histone Deacetylase Inhibitors Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 49. Argentina Histone Deacetylase Inhibitors Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 50. Middle East and Africa Histone Deacetylase Inhibitors Sales Market Share by Country (2020-2031)
 Figure 51. Middle East and Africa Histone Deacetylase Inhibitors Revenue Market Share by Country (2020-2031)
 Figure 52. Turkey Histone Deacetylase Inhibitors Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 53. Saudi Arabia Histone Deacetylase Inhibitors Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 54. U.A.E Histone Deacetylase Inhibitors Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 55. Global Sales Market Share of Histone Deacetylase Inhibitors by Type (2020-2031)
 Figure 56. Global Revenue Market Share of Histone Deacetylase Inhibitors by Type (2020-2031)
 Figure 57. Global Histone Deacetylase Inhibitors Price (US$/Dose) by Type (2020-2031)
 Figure 58. Global Sales Market Share of Histone Deacetylase Inhibitors by Application (2020-2031)
 Figure 59. Global Revenue Market Share of Histone Deacetylase Inhibitors by Application (2020-2031)
 Figure 60. Global Histone Deacetylase Inhibitors Price (US$/Dose) by Application (2020-2031)
 Figure 61. Histone Deacetylase Inhibitors Value Chain
 Figure 62. Channels of Distribution (Direct Vs Distribution)
 Figure 63. Bottom-up and Top-down Approaches for This Report
 Figure 64. Data Triangulation
 Figure 65. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Nano Dimension

SIMILAR REPORTS